Old Web
English
Sign In
Acemap
>
authorDetail
>
Helen Carlsson Nyhlén
Helen Carlsson Nyhlén
Immunology
Chemokine
CCL2
Biology
Clinical trial
3
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod.
2021
Arthritis Research & Therapy
Roger Hesselstrand
Jörg H W Distler
Gabriela Riemekasten
Dirk M. Wuttge
Marie Törngren
Helen Carlsson Nyhlén
Fredrik Andersson
Helena Eriksson
Birgitta Sparre
Helén Tuvesson
Oliver Distler
Show All
Source
Cite
Save
Citations (0)
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
2016
Journal of Dermatological Science
Martin Stenström
Helen Carlsson Nyhlén
Marie Törngren
David Liberg
Birgitta Sparre
Helén Tuvesson
Helena Eriksson
Tomas Leanderson
Show All
Source
Cite
Save
Citations (21)
Naptumomab Estafenatox, an Engineered Antibody-superantigen Fusion Protein With Low Toxicity and Reduced Antigenicity
2010
Journal of Immunotherapy
Göran Forsberg
Niels Jörgen Skartved
Marie Wallén-Öhman
Helen Carlsson Nyhlén
Kristina Behm
Gunnar Hedlund
Thore Nederman
Show All
Source
Cite
Save
Citations (29)
1